Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial.

[1]  M. McCaul,et al.  Antifibrinolytic drugs for acute traumatic injury. , 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[2]  T. Steiner,et al.  Idarucizumab for Dabigatran Reversal. , 2015, The New England journal of medicine.

[3]  Bcps,et al.  Idarucizumab for dabigatran reversal , 2015 .

[4]  F. Velasco,et al.  Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery. , 2015, Future cardiology.

[5]  I. Roberts,et al.  Antifibrinolytic drugs for acute traumatic injury. , 2015, The Cochrane database of systematic reviews.

[6]  R. Bahl,et al.  Emergency reversal of dabigatran for emergency surgery , 2015, BMJ Case Reports.

[7]  C. Samama,et al.  Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants , 2015, Critical Care.

[8]  A. Coppola,et al.  Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. , 2015, The Cochrane database of systematic reviews.

[9]  B. Gersh,et al.  Use and Outcomes Associated With Bridging During Anticoagulation Interruptions in Patients With Atrial Fibrillation , 2015, Circulation.

[10]  D. Xavier,et al.  Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. , 2014, Blood.

[11]  D. Siegal,et al.  Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. , 2014, Journal of the American College of Cardiology.

[12]  D. Siegal,et al.  Reversal of target-specific oral anticoagulants. , 2014, Drug discovery today.

[13]  J. Beyer-Westendorf,et al.  Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. , 2014, European heart journal.

[14]  J. Eikelboom,et al.  Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent. , 2014, The Canadian journal of cardiology.

[15]  G. Luijckx,et al.  Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate , 2013, Thrombosis and Haemostasis.

[16]  J. Goldstein,et al.  Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding: A Randomized, Plasma-Controlled, Phase IIIb Study , 2013, Circulation.

[17]  W. Ageno,et al.  Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis , 2013, Journal of thrombosis and haemostasis : JTH.

[18]  H. Heidbuchel,et al.  Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. , 2013, Circulation.

[19]  R. Rossaint,et al.  Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model , 2012, PloS one.

[20]  J. Douketis,et al.  Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates , 2012, Circulation.

[21]  S. Yusuf,et al.  Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial , 2012, Circulation.

[22]  J. Douketis,et al.  Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors , 2012, American journal of hematology.

[23]  J. Douketis,et al.  Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy , 2012, Journal of thrombosis and haemostasis : JTH.

[24]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[25]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[26]  J. Douketis,et al.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[27]  M. Eckman,et al.  Clinical Practice Guidelines Evidence-Based College of Chest Physicians Prevention of Thrombosis, 9th ed: American Therapy : Antithrombotic Therapy and Perioperative Management of Antithrombotic , 2012 .

[28]  I. Welters.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012 .

[29]  B. Biccard,et al.  Vascular events in noncardiac Surgery patients cohortevaluation study (Vision) Nt-pro-BNP sub study. A large multicentre international cohort study evaluating NT-pro-BNP in major vascular events in patients undergonig noncardiac surgery , 2011 .

[30]  W. Ageno,et al.  Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists , 2011, Thrombosis and Haemostasis.

[31]  D. S. Houston,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[32]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[33]  S. Stanworth,et al.  Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. , 2007, The Cochrane database of systematic reviews.

[34]  L. Goldman,et al.  Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review , 2005, Canadian Medical Association Journal.